TRAVERE THERAPEUTICS
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88758429
- Registration number
- 7115678
- Mark type
- Stylized text
- Filed
- 14 Jan 2020
- Published for opposition
- 12 May 2020
- Registered
- 18 Jul 2023
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for the treatment of rare diseases; medical research
- Class 044 — Medical, beauty and agricultural services: Providing health and medical information; providing a website featuring health and medical information
Owner
- TRAVERE THERAPEUTICS, INC., SAN DIEGO, CA, US
- TRAVERE THERAPEUTICS, INC., SAN DIEGO, CA, US
- Retrophin, Inc., San Diego, CA, US
- Retrophin, Inc., San Diego, CA, US
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jun 2023 — USE AMENDMENT FILED
- 01 Jun 2023 — TEAS STATEMENT OF USE RECEIVED
- 26 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2023 — SOU EXTENSION 5 GRANTED
- 09 Jan 2023 — SOU EXTENSION 5 FILED
- 25 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2022 — SOU EXTENSION 4 GRANTED
- 28 Jun 2022 — SOU EXTENSION 4 FILED